Insider Trading activities at Acura Pharmaceuticals, Inc (ACUR)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Acura Pharmaceuticals, Inc (ACUR) since 2007 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Acura Pharmaceuticals, Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 786947.

Total stock buying since 2007: $402,894.
Total stock sales since 2007: $23,117,872.
Total stock option exercises since 2007: $930,360.


 1   2 
19 insiders reported insider trading activities at Acura Pharmaceuticals, Inc (ACUR):
Insider trading activities of Galen Partners Iii L P
Insider trading activities of Clemens Peter A
Insider trading activities of Ross George K
Insider trading activities of Rivet J Bradley
Insider trading activities of Ramsay David Russ
Insider trading activities of Markham Richard J
Insider trading activities of Brzeczko Albert W
Insider trading activities of Skelly William G
Insider trading activities of Gce Holdings Llc
Insider trading activities of Care Capital Offshore Investments Ii Lp
Insider trading activities of Care Capital Ii Llc
Insider trading activities of Sumner William
Insider trading activities of Thangaraj Immanuel
Insider trading activities of Seiser Robert A
Insider trading activities of Wesson Bruce F
Insider trading activities of Jones Robert B
Insider trading activities of Reddick Andrew D
Insider trading activities of Essex Woodlands Health Ventures Fund V Lp
Insider trading activities of Emigh James F

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Acura Pharmaceuticals, Inc (ACUR).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 0 $0 150,000 $0
2024 0 $0 0 $0 187,500 $0
2023 0 $0 0 $0 718,664 $0
2022 0 $0 0 $0 447,662 $0
2021 0 $0 0 $0 484,829 $9,060
2020 0 $0 0 $0 341,668 $0
2019 0 $0 0 $0 266,664 $0
2018 0 $0 0 $0 237,534 $0
2017 1,896,534 $193,667 2,195,734 $219,573 103,223 $1,066
2016 0 $0 0 $0 32,815 $0
2015 0 $0 275,823 $219,601 77,206 $0
2014 102,000 $117,027 671,183 $1,343,832 43,884 $28,371
2013 1,215 $2,065 7,406,915 $18,099,999 21,825 $28,371
2012 1,000 $2,550 322,004 $1,190,737 21,825 $28,371
2011 29,754 $87,585 20,000 $76,148 134,325 $174,621
2010 0 $0 22,846 $109,756 0 $0
2009 0 $0 201,532 $1,427,824 425,000 $552,500
2008 0 $0 3,200 $16,083 0 $0
2007 214,377,768 $0 332,506 $414,319 300,000 $108,000

Table 2. Monthly summary of insider trading at Acura Pharmaceuticals, Inc (ACUR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-01 0 $0 0 $0 150,000 $0
2024-01 0 $0 0 $0 187,500 $0
2023-11 0 $0 0 $0 160,000 $0
2023-01 0 $0 0 $0 558,664 $0
2022-08 0 $0 0 $0 180,998 $0
2022-01 0 $0 0 $0 266,664 $0
2021-02 0 $0 0 $0 60,000 $9,060
2021-01 0 $0 0 $0 424,829 $0
2020-01 0 $0 0 $0 341,668 $0
2019-01 0 $0 0 $0 266,664 $0
2018-01 0 $0 0 $0 237,534 $0
2017-12 1,885,734 $188,573 2,195,734 $219,573 0 $0
2017-08 10,800 $5,094 0 $0 0 $0
2017-02 0 $0 0 $0 1,166 $1,066
2017-01 0 $0 0 $0 102,057 $0
2016-01 0 $0 0 $0 32,815 $0
2015-06 0 $0 104,823 $113,495 0 $0
2015-01 0 $0 171,000 $106,106 77,206 $0
2014-05 102,000 $117,027 20,000 $24,742 0 $0
2014-03 0 $0 2,500 $5,000 0 $0
2014-02 0 $0 648,683 $1,314,090 9,375 $12,187
2014-01 0 $0 0 $0 34,509 $16,184
2013-12 0 $0 0 $0 9,375 $12,187
2013-11 1,215 $2,065 0 $0 0 $0

Table 3. Detailed insider trading at Acura Pharmaceuticals, Inc (ACUR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-01-02 Thangaraj Immanuel Option Ex 50,000 .00 0
2025-01-02 Ross George K Option Ex 50,000 .00 0
2025-01-02 Skelly William G Option Ex 50,000 .00 0
2024-01-02 Thangaraj Immanuel Option Ex 50,000 .00 0
2024-01-02 Ross George K Option Ex 50,000 .00 0
2024-01-02 Skelly William G Option Ex 50,000 .00 0
2024-01-02 Wesson Bruce F Option Ex 37,500 .00 0
2023-11-20 Brzeczko Albert W (See Remarks) Option Ex 40,000 .00 0
2023-11-20 Jones Robert B (President & CEO) Option Ex 40,000 .00 0
2023-11-20 Seiser Robert A (VP, Treasurer & Controller) Option Ex 40,000 .00 0
2023-11-20 Clemens Peter A (Senior VP & CFO) Option Ex 40,000 .00 0
2023-01-03 Brzeczko Albert W (See Remark) Option Ex 68,000 .00 0
2023-01-03 Jones Robert B (President & CEO) Option Ex 50,000 .00 0
2023-01-03 Seiser Robert A (VP, Treasurer & Controller) Option Ex 20,000 .00 0
2023-01-03 Thangaraj Immanuel Option Ex 66,666 .00 0
2023-01-03 Ross George K Option Ex 66,666 .00 0
2023-01-03 Skelly William G Option Ex 66,666 .00 0
2023-01-03 Wesson Bruce F Option Ex 66,666 .00 0
2023-01-03 Clemens Peter A (Senior VP & CFO) Option Ex 80,000 .00 0
2022-08-03 Brzeczko Albert W (VP, Pharma Sciences - APT) Option Ex 43,333 .00 0
2022-08-03 Jones Robert B (President & CEO) Option Ex 63,666 .00 0
2022-08-03 Seiser Robert A (VP, Controller & Treasurer) Option Ex 24,666 .00 0
2022-08-03 Clemens Peter A (Senior VP & CFO) Option Ex 49,333 .00 0
2022-01-03 Thangaraj Immanuel Option Ex 66,666 .00 0
2022-01-03 Ross George K Option Ex 66,666 .00 0
2022-01-03 Skelly William G Option Ex 66,666 .00 0
2022-01-03 Wesson Bruce F Option Ex 66,666 .00 0
2021-02-24 Emigh James F (VP, Corporate Development) Option Ex 20,000 .15 3,020
2021-02-24 Clemens Peter A (Senior VP & CFO) Option Ex 40,000 .15 6,040
2021-01-04 Brzeczko Albert W (VP, Pharmaceutical Sciences) Option Ex 43,334 .00 0
2021-01-04 Jones Robert B (President & CEO) Option Ex 63,667 .00 0
2021-01-04 Seiser Robert A (VP, Treasurer & Controller) Option Ex 24,667 .00 0
2021-01-04 Thangaraj Immanuel Option Ex 54,790 .00 0
2021-01-04 Emigh James F (VP, Corporate Development) Option Ex 24,667 .00 0
2021-01-04 Ross George K Option Ex 54,790 .00 0
2021-01-04 Skelly William G Option Ex 54,790 .00 0
2021-01-04 Wesson Bruce F Option Ex 54,790 .00 0
2021-01-04 Clemens Peter A (Senior VP & CFO) Option Ex 49,334 .00 0
2020-01-02 Brzeczko Albert W (VP Pharmaceutical Sciences APT) Option Ex 9,334 .00 0
2020-01-02 Jones Robert B (President & CEO) Option Ex 13,667 .00 0
2020-01-02 Seiser Robert A (VP, Treasurer & Controller) Option Ex 4,667 .00 0
2020-01-02 Thangaraj Immanuel Option Ex 83,333 .00 0
2020-01-02 Emigh James F (VP, Corporate Development) Option Ex 4,667 .00 0
2020-01-02 Ross George K Option Ex 50,000 .00 0
2020-01-02 Skelly William G Option Ex 83,333 .00 0
2020-01-02 Wesson Bruce F Option Ex 83,333 .00 0
2020-01-02 Clemens Peter A (Senior VP & CFO) Option Ex 9,334 .00 0
2019-01-02 Thangaraj Immanuel Option Ex 66,666 .00 0
2019-01-02 Ross George K Option Ex 66,666 .00 0
2019-01-02 Skelly William G Option Ex 66,666 .00 0
2019-01-02 Wesson Bruce F Option Ex 66,666 .00 0
2018-01-02 Thangaraj Immanuel (Director) Option Ex 35,714 .00 0
2018-01-02 Ross George K (Director) Option Ex 82,774 .00 0
2018-01-02 Skelly William G (Director) Option Ex 59,523 .00 0
2018-01-02 Wesson Bruce F (Director) Option Ex 59,523 .00 0
2017-12-14 Brzeczko Albert W (VP Technical Affairs - APT) Buy 300,000 .10 30,000
2017-12-14 Jones Robert B (President and CEO) Buy 400,000 .10 40,000
2017-12-14 Seiser Robert A (VP, Controller & Treasurer) Buy 300,000 .10 30,000
2017-12-14 Emigh James F (VP Corporate Development) Buy 400,000 .10 40,000
2017-12-14 Ross George K (Director) Buy 50,000 .10 5,000
2017-12-14 Skelly William G (Director) Buy 100,000 .10 10,000
2017-12-14 Wesson Bruce F (Director) Buy 335,734 .10 33,573
2017-12-14 Galen Partners Iii L P (Other) Sale 2,195,734 .10 219,573
2017-08-29 Brzeczko Albert W (VP Technical Affairs - APT) Buy 4,000 .47 1,880
2017-08-28 Brzeczko Albert W (VP Technical Affairs - APT) Buy 2,000 .46 910
2017-08-25 Brzeczko Albert W (VP Technical Affairs - APT) Buy 4,800 .48 2,304
2017-02-07 Seiser Robert A (VP, Controller & Treasurer) Option Ex 1,166 .92 1,066
2017-01-03 Thangaraj Immanuel (Director) Option Ex 26,432 .00 0
2017-01-03 Ross George K (Director) Option Ex 735 .00 0
2017-01-03 Skelly William G (Director) Option Ex 26,432 .00 0
2017-01-03 Wesson Bruce F (Director) Option Ex 22,026 .00 0
2016-01-04 Thangaraj Immanuel (Director) Option Ex 6,185 .00 0
2016-01-04 Ross George K (Director) Option Ex 8,074 .00 0
2016-01-04 Skelly William G (Director) Option Ex 8,247 .00 0
2016-01-04 Wesson Bruce F (Director) Option Ex 10,309 .00 0
2015-06-17 Galen Partners Iii L P (10% Owner) Sale 3,900 1.05 4,095
2015-06-16 Galen Partners Iii L P (10% Owner) Sale 100,923 1.08 109,400
2015-01-12 Galen Partners Iii L P (10% Owner) Sale 35,000 .64 22,470
2015-01-09 Galen Partners Iii L P (10% Owner) Sale 36,000 .65 23,436
2015-01-08 Galen Partners Iii L P (10% Owner) Sale 100,000 .60 60,200
2015-01-02 Ross George K (Director) Option Ex 11,030 .00 0
2015-01-02 Skelly William G (Director) Option Ex 29,412 .00 0
2015-01-02 Wesson Bruce F (Director) Option Ex 36,764 .00 0
2014-05-22 Skelly William G (Director) Sale 4,600 1.23 5,658
2014-05-20 Skelly William G (Director) Sale 5,000 1.22 6,075
2014-05-19 Rivet J Bradley (VP Marketing) Buy 2,000 1.23 2,456
2014-05-19 Brzeczko Albert W (VP Technical Affairs - APT) Buy 2,000 1.20 2,400
2014-05-16 Emigh James F (VP Corporate Development) Buy 15,000 1.21 18,150
2014-05-16 Wesson Bruce F (Director) Buy 20,000 1.18 23,500
2014-05-16 Clemens Peter A (Senior VP and CFO) Buy 3,000 1.21 3,621
2014-05-15 Wesson Bruce F (Director) Buy 60,000 1.11 66,900
2014-05-14 Skelly William G (Director) Sale 2,900 1.21 3,509
2014-05-12 Skelly William G (Director) Sale 5,000 1.25 6,250
2014-05-08 Skelly William G (Director) Sale 2,500 1.30 3,250
2014-03-03 Galen Partners Iii L P (10% Owner) Sale 2,500 2.00 5,000
2014-02-28 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 51,204 2.04 104,456
2014-02-28 Galen Partners Iii L P (10% Owner) Sale 147,480 2.00 295,697
2014-02-27 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 179,968 2.04 367,134
2014-02-27 Clemens Peter A (Senior VP and CFO) Option Ex 9,375 1.30 12,187
2014-02-27 Galen Partners Iii L P (10% Owner) Sale 192,479 2.04 393,042
2014-02-26 Galen Partners Iii L P (10% Owner) Sale 11,301 1.95 22,070
2014-02-24 Galen Partners Iii L P (10% Owner) Sale 43,747 1.97 86,006
2014-02-21 Galen Partners Iii L P (10% Owner) Sale 272 1.95 530
2014-02-18 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 20,032 2.04 40,865
2014-02-18 Galen Partners Iii L P (10% Owner) Sale 2,200 1.95 4,290
2014-01-24 Emigh James F (VP Corporate Development) Option Ex 6,225 1.30 8,092
2014-01-16 Seiser Robert A (VP, Controller & Treasurer) Option Ex 6,225 1.30 8,092
2014-01-02 Thangaraj Immanuel (Director) Option Ex 22,059 .00 0
2013-12-17 Clemens Peter A (Senior VP and CFO) Option Ex 9,375 1.30 12,187
2013-11-25 Brzeczko Albert W (VP Technical Affairs - APT) Buy 1,215 1.70 2,065
2013-10-10 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 5,400 2.02 10,908
2013-10-10 Galen Partners Iii L P (10% Owner) Sale 4,200 2.05 8,610
2013-08-27 Skelly William G (Director) Sale 2,000 1.55 3,100
2013-07-15 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 31,610 2.04 64,484
2013-07-03 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 14,200 2.00 28,400
2013-07-02 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 81,082 2.04 165,407
2013-07-02 Galen Partners Iii L P (10% Owner) Sale 200,000 2.15 430,000
2013-07-01 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 500,000 2.36 1,180,000
2013-06-27 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 9,042 2.01 18,174
2013-06-26 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 28,000 2.02 56,560
2013-06-25 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 39,239 2.01 78,870
2013-06-24 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 23,000 2.03 46,689
2013-06-21 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 24,000 2.03 48,719
2013-06-20 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 36,000 2.02 72,720
2013-06-19 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 42,000 2.08 87,360
2013-06-18 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 32,000 2.13 68,160
2013-06-17 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 40,000 2.15 86,000
2013-06-17 Galen Partners Iii L P (10% Owner) Sale 20,446 2.15 43,958
2013-06-14 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 30,000 2.15 64,500
2013-06-14 Galen Partners Iii L P (10% Owner) Sale 27,814 2.15 59,800
2013-06-13 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 28,000 2.15 60,200
2013-06-12 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 32,000 2.18 69,760
2013-06-12 Galen Partners Iii L P (10% Owner) Sale 3,469 2.20 7,631
2013-06-11 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 22,000 2.17 47,740
2013-06-10 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 35,000 2.20 77,000
2013-06-10 Galen Partners Iii L P (10% Owner) Sale 9,700 2.21 21,437
2013-06-07 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 45,000 2.19 98,550
2013-06-07 Galen Partners Iii L P (10% Owner) Sale 11,796 2.19 25,833
2013-06-06 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 70,000 2.13 149,100
2013-06-06 Galen Partners Iii L P (10% Owner) Sale 10,001 2.13 21,302
2013-06-05 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 45,000 2.20 99,000
2013-06-05 Galen Partners Iii L P (10% Owner) Sale 6,650 2.21 14,696
2013-06-04 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 50,000 2.21 110,500
2013-06-04 Galen Partners Iii L P (10% Owner) Sale 22,802 2.21 50,392
2013-06-03 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 58,000 2.21 128,180
2013-05-31 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 50,000 2.26 112,999
2013-05-31 Galen Partners Iii L P (10% Owner) Sale 18,699 2.25 42,072
2013-05-30 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 40,000 2.26 90,399
2013-05-30 Galen Partners Iii L P (10% Owner) Sale 12,860 2.26 29,012
2013-05-29 Care Capital Offshore Investments Ii Lp (10% Owner) Sale 50,000 2.30 114,999
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of ACUR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Acura Pharmaceuticals, Inc (symbol ACUR, CIK number 786947) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.